For the Inventor, By the Inventor

Enter assignee name

Ab Science

USPTO Granted Patents = 28

CIPO Patents = 3

EPO Patents = 18

Trademarks = 1

Forward Citations = 58

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Alain Moussy (27 out of 27 patents)

Jean-Pierre Kinet (10 out of 15 patents)

Abdellah Benjahad (10 out of 11 patents)

4. Franck Sandrinelli (6 out of 6 patents)

5. Willy Picoul (6 out of 7 patents)

6. Didier Pez (6 out of 6 patents)

7. Jason Martin (6 out of 6 patents)

8. Emmanuel Chevenier (6 out of 6 patents)

9. Camille Georges Wermuth (6 out of 16 patents)

10. Bruno Giethlen (5 out of 23 patents)

11. Anne Lermet (4 out of 4 patents)

12. Marco Ciufolini (4 out of 4 patents)

13. Claire Schalon (3 out of 3 patents)

14. Philippe Reginault (3 out of 3 patents)

15. David Grierson (3 out of 18 patents)

28 patents: Sort by Forward Citations

1. 12472164 - Masitinib for the treatment of sickle cell disease (2025-11-18),

2. 10570122 - Compounds with anti-tumoral activity (2020-02-25),

3. 10392373 - Oxazole derivatives that inhibit Syk (2019-08-27),

4. 10238649 - Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors (2019-03-26),

5. 10202370 - Benzimidazole derivatives as selective proteine kinase inhibitors (2019-02-12),

6. 10092564 - Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation (2018-10-09),

7. 10053455 - Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors (2018-08-21),

8. 10045978 - Treatment of mastocytosis with masitinib (2018-08-14),

9. 9168245 - Selective protein kinase inhibitors (2015-10-27),

10. 9078894 - Treatment of severe persistant asthma with masitinib (2015-07-14),

11. 8993573 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2015-03-31),

12. 8962665 - Thiazole and oxazole kinase inhibitors (2015-02-24),

13. 8940894 - Aminothiazole compounds as kinase inhibitors and methods of using the same (2015-01-27),

14. 8906357 - Treatment of multiple sclerosis with masitinib (2014-12-09),

15. 8835435 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2014-09-16),

AB Science is a pharmaceutical company specializing in the research, development, and commercialization of innovative therapies for rare diseases. With a focus on oncology, neurology, and inflammatory diseases, AB Science is dedicated to improving the lives of patients and providing them with effective treatment options. Through rigorous scientific research and clinical trials, AB Science aims to bring novel therapies to market and address the unmet medical needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#170 in Paris

#746 in France

#22,565 in the World

Ab Science

Forward Citations = 58

29 inventors:

Alain Moussy (27 out of 27 patents)

Jean-Pierre Kinet (10 out of 15 patents)

Abdellah Benjahad (10 out of 11 patents)

4. Franck Sandrinelli (6 out of 6 patents)

5. Willy Picoul (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…